The first article is a commentary which proposes glucose-6 phosphate dehydrogenase (G6PD) deficiency as a factor contributing to COVID-19 morbidity and mortality (Aydemir and Ulusu, 2020). Here, G6PD is linked to hyperinsulinemic hypoglycemia, familial, 4.